CD-Chex CD117® Plus
Positive Procedural Control for Immunophenotyping
CD-Chex CD117 Plus was developed with characteristics similar to the abnormal peripheral blood leukocytes often found in a hematolymphoid neoplastic patient sample. CD-Chex CD117 Plus possesses surface CD117, CD25 and CD71 that are detectable with fluorescent monoclonal antibodies by flow cytometry. The abnormal leukocytes are distinguishable from normal leukocytes on the basis of light scatter properties and a low level of CD45 expression.
CD-Chex CD117 Plus is used to monitor reagent staining, erythrocyte lysis, sample preparation, and instrument performance and is designed for use on BD Biosciences and Beckman Coulter® flow cytometry systems. CD-Chex CD117 Plus provides abnormal and total leukocyte assay values for CD117, CD25 and CD71 and eliminates the need to hold and validate patient samples to use as a control.
Streck offers STATS®, a free Interlaboratory Quality Control program for our customers.
For Research Use Only. Not for use in diagnostic procedures.
- 90-day closed-vial stability
- 30-day open-vial stability
Click here to see patents that may be applicable to this product.
Assays & Certificates of Compliance (COC)